General Information of This Metabolic Reaction (MR) (ID:
MR000733) |
Formula |
|
Reactant |
Dapsone |
Product |
Dapsone hydroxylamine |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2E1 (CYP2E1)
|
DME Info
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Myeloperoxidase (MPO)
|
DME Info
|
Cytochrome c oxidase subunit 2 (MT-CO2)
|
DME Info
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-Hydroxylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population Clin Sci (Lond). 2009 Oct 26;118(3):187-94. doi: 10.1042/CS20090142.
|
2 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.